Healthcare News and Headlines
Healthcare News and Headlines
Healthcare Pulse
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
EMAIL DIGESTS
Daily
Every morning
Weekly
Tuesday recap
A recent LinkedIn post by Wayne Gillis points out that neither Rehoboth McKinley nor Great Falls Clinic uses Epic’s electronic health record platform, contradicting earlier assumptions. The post also notes that Rehoboth McKinley operates a Cerner/Oracle patient portal, highlighting ongoing EHR diversification. Parallel discussions on LinkedIn have revived interest in direct‑to‑consumer (DTC) laboratory testing and its distinction from Direct Access Testing (DAT). These conversations underscore broader industry debates about health‑IT interoperability and consumer‑driven diagnostics.
A new BMJ meta‑analysis of over 600,000 U.S. veterans with type‑2 diabetes found that patients prescribed GLP‑1 agonists such as semaglutide or tirzepatide were 14% less likely to develop substance‑use disorders (SUD) than those on SGLT2 inhibitors. Over a three‑year...
Airiver Medical announced that the U.S. Food and Drug Administration granted Breakthrough Device Designation to its pulmonary drug‑coated balloon (DCB) for treating central airway stenosis. The company also enrolled and treated the first patient in a pivotal trial that will...
Amazon Web Services unveiled Amazon Connect Health, an agentic AI platform that plugs directly into electronic health records to automate patient verification, appointment scheduling, ambient documentation, and medical coding. The service, built on FHIR standards and Amazon HealthLake, offers a...
Targeted therapies are reshaping oncology, yet chemotherapy remains essential. Immune checkpoint inhibitors like Keytruda generate $31.7 bn sales in 2025 and cover more than 40 indications. The FDA granted 63 antibody‑drug conjugate review designations in 2024, nearly double the previous peak....
Suffolk and North East Essex Integrated Care Board has issued a £5.2 million contract to modernise GP IT systems in line with the Primary Care Digital Services Model. The three‑year agreement, starting 1 December 2026, can be extended to 2031 and requires a...
The FDA has begun reviewing Hansa Biopharma’s imlifidase, a drug that desensitises highly sensitised kidney‑transplant patients, with a decision expected by December 19, 2024. If approved, it would be the first U.S. therapy to improve transplant odds for the 10‑15 % of...
A recent HTN audience survey, presented by Aire Innovate’s Ian Dove and Fiona Costello, identified persistent pain points in NHS digital systems. Staff cite inadequate training, top‑down development, poor interoperability and extensive manual workarounds, while IT capacity backlogs stretch change...
Akeso presented Phase‑II COMPASSION‑03 data for cadonilimab in patients with recurrent or metastatic cervical cancer who progressed after platinum chemotherapy. The trial reported a median overall survival of 17.5 months across the cohort, with 24‑month OS rates of 40.9% irrespective...
Philips has introduced Rembra, a next‑generation CT system built for acute and high‑throughput imaging environments. The scanner delivers ultra‑fast reconstruction speeds of up to 106 images per second and can support as many as 270 examinations per day. It features...
Surgeons at Hampshire Hospitals NHS Foundation Trust have performed their 100th operation using the da Vinci 5 robotic‑assisted surgical system, just six months after becoming the first UK NHS trust to install the next‑generation robot. The system, deployed at Basingstoke...
GAIA and Daiichi Sankyo Europe announced an exclusive partnership to commercialize lipodia, a next‑generation digital therapeutic for hypercholesterolemia, pending regulatory approval. The deal grants Daiichi exclusive rights in Germany with expansion mechanisms for other European markets, leveraging GAIA’s validated behavioral...
Health insurance coverage is slipping for many Americans as ACA marketplace sign‑ups fell by roughly one million this year and federal subsidies expired, driving premiums higher. Stricter Medicaid eligibility rules further limit options for low‑income households. KFF Health News correspondent...
HUTCHMED has launched a first‑in‑human Phase I/IIa trial of HMPL‑A580, its second antibody‑targeted therapy conjugate, in the United States and China. The multi‑centre, open‑label study will evaluate safety, tolerability, immunogenicity, pharmacokinetics and early efficacy across dose‑escalation and expansion cohorts. HMPL‑A580...
Affinia Therapeutics announced that the FDA has granted fast‑track designation to its gene‑therapy candidate AFTX‑201 for BAG3‑associated dilated cardiomyopathy. The one‑time intravenous treatment delivers a full‑length BAG3 transgene via an engineered capsid that requires doses five to ten times lower...
Researchers repurposed the FAP inhibitor SP‑13786 as a co‑assembly excipient to create SP co‑assembled nanoparticles (SCAN) that encapsulate hydrophobic drugs. Using molecular dynamics and a random‑forest machine‑learning model, they identified 228 physicochemical descriptors that predict successful nano‑co‑assembly, highlighting aromaticity and...
MedTech is moving from a hospital‑centric model to a consumer‑driven ecosystem, with at‑home diagnostics, wellness tools, and direct‑to‑consumer devices reshaping adoption. Design teams must prioritize motivation, habit and identity over pure clinical protocol, making products feel like lifestyle accessories rather...
Gilead Sciences is in talks with the South African government to issue a voluntary licence for the local manufacture of lenacapavir, a novel HIV‑prevention drug. The agreement would enable South African firms, identified with help from Unitaid and the US...
Tim O’Connell, CEO of emtelligent, argues that most HEDIS‑critical information resides in unstructured clinical text, not traditional fields. Over 80% of healthcare data is narrative, leaving a compliance gap that can cost plans millions in lower Star Ratings. He highlights...
Caltech researchers unveiled visual surface wave elastography, a technique that captures imperceptible skin vibrations with a smartphone camera to infer the stiffness and thickness of underlying tissue. By applying phase‑based motion processing and spectral analysis, the method extracts subpixel movements...
The FDA released a draft Level 1 guidance titled “New Clinical Investigation Exclusivity (3‑Year Exclusivity) for Drug Products: Questions and Answers.” The document clarifies statutory and regulatory criteria for obtaining three‑year market exclusivity on new drug applications or supplements. It outlines...
Researchers at the Institute of Science Tokyo directly traced small extracellular vesicles (sEVs) from tumors to urine in mouse models of brain, lung and pancreatic cancer. Using engineered RNA tracers and luminescent‑fluorescent reporters, they showed tumor‑derived sEVs appear in urine...
Medtronic reported Q3 2026 revenue of $9 billion, up 8.7% YoY, driven by an 11% surge in its cardiovascular portfolio and an 80% jump in Cardiac Ablation Solutions (CAS) where pulse‑field ablation now accounts for 80% of the segment. Gross margin...
CONMED reported Q4 2025 revenue of $373.2 million, a 7.9% year‑over‑year increase, and full‑year sales of $1.375 billion, up 5.2%. Orthopedic sales jumped 12.1% in the quarter, while international sales surged 15.4%, offsetting modest U.S. growth. Adjusted EPS rose 6.7% to $1.43,...
Syndax Pharmaceuticals reported $172 million total revenue for 2025, driven by $125 million from its menin inhibitor RevuForge and $152 million from chronic GVHD therapy Nictimvo. RevuForge saw 38% quarter‑over‑quarter revenue growth and a 35% rise in prescriptions, bolstered by an expanded NPM1...
Sensus Healthcare reported Q4 2025 revenue of $4.9 million, an 84% decline from the prior year, driven by the loss of its largest customer. Gross margin fell to 38.8% as servicing costs rose, while the company posted a $3.2 million net loss....
TriSalus Life Sciences reported Q3 2025 revenue of $11.6 million, a 57% year‑over‑year increase, while adjusted EBITDA loss narrowed to $5.4 million despite one‑time study charges. Gross margin slipped to 84% as new product launches strained manufacturing efficiency, but cash burn improved,...
Agilon Health reported FY 2025 revenue of $5.93 billion, with Q4 revenue of $1.57 billion, but both medical margin and adjusted EBITDA remained negative, driven by higher inpatient claims and market exits. The company cut operating expenses by $35 million and extended its...
Compugen Ltd. reported a dramatic financial turnaround in its Q4 2025 earnings, posting a $56.8 million quarterly profit and $35.3 million annual profit after a year of losses. A $65 million upfront royalty monetization from AstraZeneca boosted cash to $145.6 million, extending the cash runway...
CommonSpirit Health at Home is charting a 2026 roadmap that moves care upstream by using EHR‑based eligibility triggers to engage patients earlier in hospice and home‑health pathways. The provider plans a measured AI rollout focused on predictive analytics and operational...
CordenPharma Colorado has signed a 15‑year lease for a 64,000 SF purpose‑built lab in Boulder’s Flatiron Park, expanding its peptide development capabilities adjacent to an existing manufacturing plant. The speculative building, completed in 2024, features adaptable lab grids, advanced utilities and specialized...
Best in KLAS 2026 delivers a data‑driven analysis of healthcare technology solutions, ranking platforms by performance ratings, measurable outcomes, and innovation trajectories. It aggregates validated customer feedback and market performance data to help executives de‑risk technology investments. The report highlights...
A recent Hematology Reports review examined 15 randomized trials that integrated patient‑reported outcome measures (PROMs) into leukemia research. The analysis found that PROMs such as EORTC QLQ‑C30 and EQ‑5D not only captured quality‑of‑life domains but also independently predicted overall survival...
Healthcare technology firms are increasingly embedding Ambient Clinical Intelligence (ACI) into EHR, telehealth, and care‑management platforms to cut administrative load and speed revenue cycles. Building ACI models internally demands extensive engineering resources, prompting many vendors to seek external expertise. Suki’s...
Google Cloud’s 2026 report spotlights five AI‑agent trends reshaping healthcare and life sciences, from automating clinical paperwork to accelerating drug discovery. The analysis stresses that unlocking AI value requires leaders to discard legacy mindsets and foster a culture that embraces...
The FDA’s GDUFA Type II API DMF payment report shows 385 payments in FY 2023, a dip to 264 in FY 2024, a rebound to 374 in FY 2025, and 90 early‑year payments in FY 2026. Monthly counts reveal a pronounced September 2023 spike of 103...
The FDA is holding its Fiscal Year 2026 Generic Drug Science and Research Initiatives public workshop on June 8‑9, offering both in‑person and virtual attendance. The two‑day event will review current research gaps and solicit stakeholder input to shape the FY 2027...
Preliminary trials of Zorevunersen, an experimental therapy for Dravet syndrome, showed it is safe and well tolerated in 81 children. A single 70 mg dose reduced seizures by about 50%, and three doses cut seizures roughly 80% compared with baseline. The...
Proscia topped the KLAS Research Digital Pathology 2026 report with a 95.2 overall performance score, the highest among U.S. vendors. The company earned A+ and A grades across six customer‑experience categories, and every surveyed client said they plan to keep...
The American Medical Association has granted a Category 3 CPT code (X567T) to AIQ Solutions’ TRAQinform IQ, an AI‑enabled lesion quantification platform cleared by the FDA in 2018. The tool analyzes changes in lesion size and metabolic activity, providing clinicians with more...
A pooled analysis of the MOMENTUM 3 and ARIES‑HM3 trials involving 1,983 HeartMate 3 LVAD recipients identified an optimal early mean arterial pressure (MAP) of 85‑100 mm Hg, with 85‑95 mm Hg appearing ideal. Patients who spent more time within this range during the first 90...
A study published in the Journal of Otolaryngology‑ENT Research found that Nuance Audio Glasses, an over‑the‑counter hearing solution from EssilorLuxottica, improve speech‑reception thresholds by an average of 3.48 dB in noisy environments. Twenty adults with mild‑to‑moderate hearing loss achieved 50 % word...
The CDC reports that the U.S. maternal mortality rate fell to 17.9 deaths per 100,000 live births in 2024, a figure statistically indistinguishable from the 18.6 recorded in 2023. Black women experienced a mortality rate of 44.8 per 100,000, far...
The American Hospital Association (AHA) announced that the application deadline for its Next Gen fellowship is March 31. The program targets emerging healthcare leaders, offering mentorship, networking, and strategic projects across member hospitals. Applicants must submit a brief proposal outlining a health‑system...
The American Hospital Association released a multi‑segment podcast highlighting how hospitals are expanding beyond clinical walls to address social determinants of health. Leaders from Manatt Health, CommonSpirit Health, Inova Health System, and Owensboro Health discuss initiatives tackling food insecurity, workforce...
The FDA has eliminated risk evaluation and mitigation strategy (REMS) requirements for embryofetal toxicity (EFT) across all endothelin receptor antagonist (ERA) medicines, concluding that labeling alone sufficiently communicates the risk. The change, effective April 2025, applies to ambrisentan, macitentan‑containing products, and...
Relief Cardiovascular unveiled its AI‑enabled Relief System, an implantable valve and sensor that modulates inferior vena cava pressure to boost renal perfusion in diuretic‑resistant heart‑failure patients. In the first‑in‑human RELIEF‑FIH study of eight European participants, the device achieved 100% procedural...
Healthcare finance leaders are pouring capital into AI and automation to solve revenue cycle management (RCM) challenges, yet many are discovering that automating flawed workflows only accelerates errors. The emerging "automation paradox" shows that without clean data and standardized processes,...
MYQORZO (aficamten), a cardiac myosin inhibitor, received FDA approval on Dec 19 2025 for adults with symptomatic obstructive hypertrophic cardiomyopathy (oHCM). Approval is based on the SEQUOIA‑HCM phase III trial, a randomized, double‑blind, placebo‑controlled study of 282 patients across 14 countries. At 24 weeks,...
A recent JAMA Network Open study of over 1.5 million women shows Medicaid expansion under the ACA lowered breast cancer mortality by 4.8% compared with non‑expansion states. Hispanic patients experienced the largest relative gain—a 19% hazard reduction—while Black women saw modest...
